Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jessica Wihl"'
Autor:
Jessica Wihl, Victor Falini, Sixten Borg, Olof Stahl, Thomas Jiborn, Bjorn Ohlsson, Mef Nilbert
Publikováno v:
Cancer Medicine, Vol 12, Iss 14, Pp 15149-15158 (2023)
Abstract Background Multidisciplinary team meetings (MDTMs) provide an integrated team approach to ensure individualized and evidence‐based treatment recommendations and best expert advice in cancer care. A growing number of patients and more compl
Externí odkaz:
https://doaj.org/article/d828d114a26e4b2eb20c80b4136fd701
Publikováno v:
Current Oncology, Vol 28, Iss 1, Pp 1008-1016 (2021)
Background: Multidisciplinary team (MDT) meetings provide treatment recommendations based on available information and collective decision-making in teams with complementary professions, disciplines and skills. We aimed to map ancillary medical and n
Externí odkaz:
https://doaj.org/article/0424d9a138784481901960516654e3ae
Autor:
Jessica Wihl, Linn Rosell, Pär-Ola Bendahl, Camila B.R. De Mattos, Sara Kinhult, Gert Lindell, Fredrik Vult von Steyern, Mef Nilbert
Publikováno v:
Cancer Treatment and Research Communications, Vol 25, Iss , Pp 100231- (2020)
Objectives: High-quality leadership and chairing skills are central components in team performance during multidisciplinary team (MDT) meetings. We hypothesized that the recently developed A Tumor Leadership Assessment inStrument (ATLAS) could provid
Externí odkaz:
https://doaj.org/article/232872f11606402a911ce176ef134d93
Publikováno v:
Rare Tumors, Vol 11 (2019)
National virtual multidisciplinary team meetings have been established in Swedish cancer care in response to centralized treatment of rare cancers. Though national meetings grant access to a large multidisciplinary network, we hypothesized that video
Externí odkaz:
https://doaj.org/article/7a91891d5d914887aa0f08e892f4e4d5
Autor:
Gert Lindell, Pär-Ola Bendahl, Jessica Wihl, Camila B.R. De Mattos, Mef Nilbert, Fredrik Vult von Steyern, Sara Kinhult, Linn Rosell
Publikováno v:
Wihl, J, Rosell, L, Bendahl, P O, De Mattos, C B R, Kinhult, S, Lindell, G, von Steyern, F V & Nilbert, M 2020, ' Leadership perspectives in multidisciplinary team meetings; observational assessment based on the ATLAS instrument in cancer care ', Cancer Treatment and Research Communications, vol. 25, 100231 . https://doi.org/10.1016/j.ctarc.2020.100231
Cancer Treatment and Research Communications, Vol 25, Iss, Pp 100231-(2020)
Cancer Treatment and Research Communications, Vol 25, Iss, Pp 100231-(2020)
Objectives High-quality leadership and chairing skills are central components in team performance during multidisciplinary team (MDT) meetings. We hypothesized that the recently developed A Tumor Leadership Assessment inStrument (ATLAS) could provide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5570ac257a82fde0b7a0235185919736
https://curis.ku.dk/ws/files/260245707/1_s2.0_S2468294220300666_main.pdf
https://curis.ku.dk/ws/files/260245707/1_s2.0_S2468294220300666_main.pdf
Autor:
Björn Ohlsson, Katarina Steen Carlsson, Mef Nilbert, Jessica Wihl, Nathalie Alexandersson, Linn Rosell
Publikováno v:
Acta Oncologica. 57:675-680
Background: Multidisciplinary team meetings (MDTMs) have developed into standard of care to provide expert opinion and to grant evidence-based recommendations on diagnostics and treatment of cancer. Though MDTMs are associated with a range of benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f639c097a74d546f6050e1e2d47c244
https://doi.org/10.1080/0284186x.2017.1400682
https://doi.org/10.1080/0284186x.2017.1400682
Publikováno v:
Journal of Multidisciplinary Healthcare
Purpose Multidisciplinary team meetings (MDTMs) are an integral component of cancer care. Increasingly, virtual MDTMs are used to grant high-quality treatment recommendations across health-care regions, which expands and develops the local MDTM team
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b23cf073c7b8a75a243269e7f717f722
https://pubmed.ncbi.nlm.nih.gov/32103978
https://pubmed.ncbi.nlm.nih.gov/32103978
Publikováno v:
Rare Tumors
Rosell, L, Wihl, J, Hagberg, O, Ohlsson, B & Nilbert, M 2019, ' Function, information, and contributions : An evaluation of national multidisciplinary team meetings for rare cancers ', Rare Tumors, vol. 11, 2036361319841696 . https://doi.org/10.1177/2036361319841696
Rare Tumors, Vol 11 (2019)
Rosell, L, Wihl, J, Hagberg, O, Ohlsson, B & Nilbert, M 2019, ' Function, information, and contributions : An evaluation of national multidisciplinary team meetings for rare cancers ', Rare Tumors, vol. 11, 2036361319841696 . https://doi.org/10.1177/2036361319841696
Rare Tumors, Vol 11 (2019)
National virtual multidisciplinary team meetings have been established in Swedish cancer care in response to centralized treatment of rare cancers. Though national meetings grant access to a large multidisciplinary network, we hypothesized that video
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aebe6a05ba5f89148d9eb97f5d840032
http://europepmc.org/articles/PMC6506921
http://europepmc.org/articles/PMC6506921
Autor:
Troels K Bergmann, Nina Keldsen, Kristin Skougaard, Kim Brøsen, Henrik Gréen, Charlotte Brasch-Andersen, Mansoor Raza Mirza, Werner Vach, Per Damkier, Jessica Wihl, Carsten Peterson
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 110:199-204
The standard treatment for ovarian cancer in advanced stages is post-surgery treatment with taxane-platin chemotherapy. Despite an initial high response rate, most patients eventually relapse. The dose-limiting toxicities of paclitaxel are neutropeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fa4f43981eacadecb2041bb0dab37b4
https://doi.org/10.1111/j.1742-7843.2011.00802.x
https://doi.org/10.1111/j.1742-7843.2011.00802.x
Autor:
Bente Lund, Jessica Wihl, Marianne Waldstrøm, Anders Jakobsen, Ignace Vergote, Christian Marth, Kjell Bergfeldt, Karina Dahl Steffensen, Niels Pallisgård, Nina Keldsen
Publikováno v:
Steffensen, K D, Waldstrøm, M, Pallisgård, N, Lund, B, Bergfeldt, K, Wihl, J, Keldsen, N, Marth, C, Vergote, I & Jakobsen, A 2013, ' Panitumumab and Pegylated Liposomal Doxorubicin in Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-Type : The PaLiDo Study, a Phase II Nonrandomized Multicenter Study ', International Journal of Gynecological Cancer, vol. 23, no. 1, pp. 73-80 . https://doi.org/10.1097/IGC.0b013e3182775fae
Steffensen, K D, Waldstrøm, M, Pallisgård, N, Lund, B, Bergfeldt, K, Wihl, J, Keldsen, N, Marth, C, Vergote, I & Jakobsen, A 2013, ' Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type : the PaLiDo study, a phase II nonrandomized multicenter study ', International Journal of Gynecological Cancer, vol. 23, no. 1, pp. 73-80 . https://doi.org/10.1097/IGC.0b013e3182775fae
Steffensen, K D, Waldstrøm, M, Pallisgård, N, Lund, B, Bergfeldt, K, Wihl, J, Keldsen, N, Marth, C, Vergote, I & Jakobsen, A 2013, ' Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type : the PaLiDo study, a phase II nonrandomized multicenter study ', International Journal of Gynecological Cancer, vol. 23, no. 1, pp. 73-80 . https://doi.org/10.1097/IGC.0b013e3182775fae
5052 Background: Ovarian cancer (OC) patients with platinum-resistant recurrent disease have few therapeutic options and the response rates are only 10-20% using non-cross-resistant chemotherapeutic agents. The increasing number of negative trials fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f58247d5eadab895db7994cc1df745b
https://portal.findresearcher.sdu.dk/da/publications/ad561978-6a40-46bf-b791-9e7cea04d4a7
https://portal.findresearcher.sdu.dk/da/publications/ad561978-6a40-46bf-b791-9e7cea04d4a7